Concepedia
Statistics
Publications
4
Citations
99
H-Index
Active since
2017
Affiliations
Novartis (India)(Current)
Novartis (United States)
Medical University of Vienna
National and Kapodistrian University of Athens
Hospital de León
Chaitali Babanrao Pisal is an author at Novartis (India) specializing in oncology, cancer pharmacology, and pharmacology.
Publications per year
2017–2021
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma
Anas Younes, Gilles Salles, Giovanni Martinelli et al. · Haematologica · 2017 · 46 citations · Full text
Medicine, Oncology, Pharmacology +14
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)
Manuela Schmidinger, Aristotelis Bamias, Giuseppe Procopio et al. · The Oncologist · 2019 · 29 citations · Full text
Medicine, Oncology, Pharmacology +17
Real-world Effectiveness and Safety of Pazopanib in Patients With Intermediate Prognostic Risk Advanced Renal Cell Carcinoma
Giuseppe Procopio, Aristotelis Bamias, Manuela Schmidinger et al. · Clinical Genitourinary Cancer · 2019 · 12 citations · Full text
Medicine, Oncology, Pharmacology +9
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study)
Mathias Rummel, Ann Janssens, David MacDonald et al. · British Journal of Haematology · 2021 · 12 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +15
1–4 of 4